Full Answer
Who buys MMLP stock?
MMLP stock was acquired by a variety of institutional investors in the last quarter, including Arrow Investment Advisors LLC. Company insiders that have bought Martin Midstream Partners stock in the last two years include C Scott Massey, Chris H Booth, Randall Tauscher, Robert D Bondurant, Ruben S Martin and Scot A Shoup.
Where can I buy shares of MMP?
Shares of MMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Should you hold Magellan Midstream Partners (MMP) stock?
The consensus among Wall Street research analysts is that investors should "hold" Magellan Midstream Partners stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MMP, but not buy additional shares or sell existing shares.
What is the earnings guidance for MMP?
Magellan Midstream Partners updated its first quarter 2022 earnings guidance on Monday, February, 7th. The company provided earnings per share (EPS) guidance of $1.020-$1.020 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.040. The company issued revenue guidance of -. What price target have analysts set for MMP?
Is MMP a good stock to buy?
The upgrade of Magellan Midstream to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021.
Will MMP stock go up?
Analyst Price Target on MMP Based on 7 Wall Street analysts offering 12 month price targets for Magellan Midstream in the last 3 months. The average price target is $55.57 with a high forecast of $59.00 and a low forecast of $52.00. The average price target represents a 11.65% change from the last price of $49.77.
Is MMP an ETF?
Magellan Midstream Partners is engaged in the transportation, storage and distribution of refined petroleum products and crude oil....ETFMMPShares Out.211.56MMarket Cap.10.23BDiv/Shr1.0375Div Yield8.5910 more rows
What sector is MMP?
The Company is principally engaged in the transportation, storage and distribution of refined petroleum products.
Is MMP a Buy Sell or Hold?
The consensus among 11 Wall Street analysts covering (NYSE: MMP) stock is to Buy MMP stock.
Does MMP pay a dividend?
Magellan Midstream (MMP) does not pay a dividend.
Is MMP a MLP?
Magellan Midstream Partners (NYSE:MMP) is an investment grade MLP with no IDR structure to suck profits from investors into the bank accounts of management.
Is Magellan Midstream a good investment?
Magellan Midstream Partners, L.P. - Hold Zacks' proprietary data indicates that Magellan Midstream Partners, L.P. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the MMP shares relative to the market in the next few months.
Who owns Magellan Midstream?
Magellan Midstream Partners LP (NYSE:MMP) Institutional investors hold a majority ownership of MMP through the 53.21% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Oil & Gas Pipelines industry.
What is MMP medical?
Medicare-Medicaid Plan (MMP) Enrollment.
When will Monopar start clinical trials?
Monopar believes that it will be able to initiate the run-in clinical trial in the second half of 2021 in the U.S. or another country.The USPTO allowed a new patent with claims covering compositions of matter for a novel family of camsirubicin analogs (2-pyrrilino camsirubicins).
What is Monopar Therapeutics?
(Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that it will present its oropharyngeal cancer (OPC) patient population analysis of the Phase 2 Validive® (clonidine HCl MBT) trial for the prevention of chemoradiotherapy-induced severe oral mucositis in head and nec
What is a monopar?
Monopar Therapeutics Inc (NASDAQ: MNPR) has announced the publication of a peer-reviewed study that demonstrated Monopar's Urokinase plasminogen activator (uPA) antibody fragment radiotracer could potentially identify breast cancers with uPA overexpression and monitor uPA activity during treatment using PET imaging. uPA is an established biomarker in current breast cancer clinical practice guidelines, and its presence is used to select appropriate drug treatment. Monopar has a panel of proprietary antibodies and antibody fragments to uPA and its receptor uPAR (such as MNPR-101). The company's antibody fragment (ATN-291 F (ab')2) conjugated to a copper radiotracer enabled rapid PET visualization of tumors with uPA overexpression in a human breast cancer model in mice. Price Action: MNPR shares are up 12.3% at $6.47 in market trading hours on the last check Tuesday. See more from BenzingaClick here for options trades from BenzingaBioNTech Stock Is Trading Higher On First Annual Profit; Raises 2021 Production Target For COVID-19 Shots To 2.5B DosesFDA Accepts AbbVie's Atogepant US Review Application For Migraine© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
When will Monopar patent Ac225?
On May 24, 2021, Monopar and NorthStar announced the filing of a provisional patent which may enable them to manufacture antibody-PCTA-Ac225 conjugates using less antibody and less Ac-225 starting material, and may also confer efficacy and safety advantages while also improving supply chain logistics.
What is the dividend payout ratio for Magellan Midstream?
Based on EPS estimates, Magellan Midstream Partners will have a dividend payout ratio of 98.80% in the coming year. This indicates that Magellan Midstream Partners may not be able to sustain their current dividend.
When is Magellan Midstream Partners earnings call?
Magellan Midstream Partners will be holding an earnings conference call on Thursday, July 29th at 1:30 PM Eastern. Interested parties can register for or listen to the call using this link.
Is MMP a dividend payer?
MMP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Magellan Midstream Partners does not yet have a strong track record of dividend growth. The dividend payout ratio of Magellan Midstream Partners is 107.03%.
About Martin Midstream Partners
Martin Midstream Partners LP engages in a diverse set of operations focused primarily in the United States Gulf Coast region. It operates through the following segments: Terminalling and Storage, Transportation, Sulfur Services, and Natural Gas Liquids.
Headlines
Albert D Mason Inc Buys PagSeguro Digital, Gilead Sciences Inc, Walgreens Boots Alliance Inc, ...
Martin Midstream Partners (NASDAQ:MMLP) Frequently Asked Questions
Martin Midstream Partners' stock was trading at $1.52 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MMLP stock has increased by 97.4% and is now trading at $3.00. View which stocks have been most impacted by COVID-19.